Efficacy of osimertinib in the treatment of EGFR mutation-positive NSCLC complicated with malignant pleural effusion
Objective To investigate the efficacy of osimertinib, a third-generation epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI), in the treatment of EGFR mutation-positive (EGFR m+) non-small cell lung cancer (NSCLC) complicated with malignant pleural effusion (MPE). Methods Retrosp...
Kaydedildi:
| Asıl Yazarlar: | , , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Chinês |
| Baskı/Yayın Bilgisi: |
Editorial Office of Journal of Xuzhou Medical University
2026-02-01
|
| Seri Bilgileri: | 徐州医科大学学报 |
| Konular: | |
| Online Erişim: | https://xb.xzhmu.edu.cn/article/doi/10.12467/j.issn.2096-3882.20250673 |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|